Village Farms International (VFF) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
30 Mar, 2026Executive summary
Achieved record profitability, gross margin, and cash flow from operations in 2025, with net income from continuing operations of $21 million and adjusted EBITDA of $49.9 million, marking a significant improvement over 2024.
Global cannabis sales grew 70% year-over-year, with international export sales increasing more than six-fold, driven by expansion in the Netherlands and strong demand in Germany.
Q4 consolidated net sales rose 9% year-over-year to $49.6 million, led by Canadian cannabis and Netherlands contributions.
Transitioned legacy produce business to private ownership, allowing focus on cannabis operations and retaining greenhouse asset optionality.
Ended 2025 with $86 million in cash and completed $6.7 million in share repurchases since Q3.
Financial highlights
Full-year consolidated net sales reached $228 million, up 12% year-over-year, with Q4 net sales of $49.6 million.
Q4 consolidated gross margin improved to 39% from 16% year-over-year; full-year gross margin was 41%.
Q4 adjusted EBITDA from continuing operations was $8.6 million (17.3% margin), up from -$2.9 million (-6.4%) in Q4 2024.
Q4 net income from continuing operations was $2.3 million, compared to a $5.7 million loss in Q4 2024.
Ended Q4 with $86 million in cash and $34 million in total debt, maintaining a strong net cash position.
Outlook and guidance
Expansion projects in Canada and the Netherlands remain on schedule and under budget, with significant new cultivation capacity expected in 2026.
Expecting sequential growth in international exports in Q1 2026 and new jurisdiction shipments in coming months.
Management remains focused on balanced capital allocation, ongoing share repurchases, and opportunistic growth investments.
Anticipates continued strong demand and plans to scale production to meet market needs.
Latest events from Village Farms International
- All director nominees and motions were approved, with final results to be published.VFF
AGM 20243 Feb 2026 - Record sales growth in Canadian cannabis and produce, but net loss widened by U.S. impairment.VFF
Q2 20242 Feb 2026 - Q3 sales up 20%, driven by Canadian cannabis, fresh produce, and international growth.VFF
Q3 202416 Jan 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20256 Jan 2026 - Full-year sales up 18% to CAD 336M; international medicinal sales to triple in 2025.VFF
Q4 202425 Dec 2025 - Plans to raise up to $200 million for growth via a multi-security shelf registration.VFF
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and diversity.VFF
Proxy Filing2 Dec 2025 - Canadian Cannabis EBITDA up 64%, international exports up 285%, $40M produce asset sale.VFF
Q1 202526 Nov 2025 - Record Q2 profit, surging cannabis margins, and global expansion drive strong outlook.VFF
Q2 202523 Nov 2025